Berkeley News Archive
Kenjiro Ono et al., 2020, studied the impact of the polyphenolic acids 3-hydroxybenzoic acid (3-HBA), 3,4-dihydroxybenzoic acid (3,4-diHBA), and 3-hydroxyphenylacetic acid (3-HPPA) (derived from gut microbiota-based metabolism of dietary polyphenols) on the brain, and demonstrated their ability to inhibit S oligomerization and mediate aggregate S-induced neurotoxicity in vitro [255]
93,94,95,96 Advancements in carrier technology and nucleic acid modification techniques have led to significant progress in overcoming these challenges, as exemplified by the first siRNA drug, patisiran (Onpattro), which has been approved for treating hereditary transthyretin-mediated amyloidosis by degrading mRNA encoding transthyretin (TTR)
Supports optimal functioning of the immune system
Fasting, fats, and physics: combining ketogenic and radiation therapy against cancer
All articles involving human subjects and published between 2005/01/01 and 2022/09/01 were selected for screening
